Episode 883
TWiV 883: COVID-19 clinical update #108 with Dr. Daniel Griffin
April 2, 202245m 25s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #107, Daniel Griffin reviews vaccine booster doses, at-home testing, transmission in ferrets, improving indoor air quality, trials of BCG, ivermectin, and fluvoxamine, vaccination during pregnancy, mRNA vaccines and Fc functions, anti-platelet and aspirin therapy and a trial of prone positioning.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- FDA authorizes second booster (FDA)
- Second booster and mortality (Res Square)
- Booster effectiveness vs hospitalization (MMWR)
- SARS-CoV-2 confections (Lancet)
- At-home testing (MMWR)
- Transmission study in ferrets (PLoS Path)
- Improving indoor air quality (EPA)
- BCG vaccine no effect on viral infections (Clin Inf Dis)
- Vaccination during pregnancy (JAMA)
- mRNA vaccines and different Fc functions (Sci Transl Med)
- Ivermectin clinical trial (NEJM)
- Fluvoxamine clinical trial (Lancet)
- Antiplatelet therapy (JAMA)
- Aspirin and in-hospital mortality (JAMA)
- Proning trial (Brit Med J)
- Dr. Griffin's treatment guide (pdf)
- Contribute to ASTMH fundraiser at PWB 41:20
- Letters read on TWiV 883
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]